NCT01205776 - EXCEL Clinical Trial | Biotech Hunter

Enrollment

1,905

Participants

Timeline

Start Date

September 29, 2010

Primary Completion Date

May 3, 2019

Study Completion Date

June 28, 2019

Conditions

Chronic Coronary OcclusionUnprotected Left Main Coronary Artery DiseaseStent ThrombosisVascular DiseaseMyocardial IschemiaCoronary Artery StenosisCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis

Interventions

DEVICE

Percutaneous Coronary Intervention

Those patients receiving the XIENCE PRIME™ EECSS or XIENCE V® EECSS or XIENCE Xpedition™ EECSS or XIENCE PRO EECSS

PROCEDURE

CABG

Those patients receiving CABG

Trial Locations (1)

95054

Abbott Vascular, Santa Clara